The article “Settled: Patent characteristics and litigation outcomes in the pharmaceutical industry,” explores the relationship between Paragraph IV litigation characteristics and the probability of a Paragraph IV settlement in the…
The post Unveiling …
Unveiling the Secrets of Patent Litigation and Settlements in Pharmaceuticals Read Post »
Annual Drug Patent Expirations for LAZANDA Lazanda is a drug marketed by Btcp Pharma and is included in one NDA. There are five patents protecting this drug. This drug has…
The post New patent expiration for Btcp Pharma drug LAZANDA appeared first on D…
New patent expiration for Btcp Pharma drug LAZANDA Read Post »
This chart shows the pharmaceutical companies with the most patents in Hong Kong. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…
The post Which pharmaceutical companies have the most drug paten…
Which pharmaceutical companies have the most drug patents in Hong Kong? Read Post »
This chart shows the drugs with the most patents in Philippines. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Phi…
Which pharmaceutical drugs have the most drug patents in Philippines? Read Post »
Annual Drug Patent Expirations for BRYHALI Bryhali is a drug marketed by Bausch and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent for Bausch drug BRYHALI appeared first on DrugPatentWat…
This chart shows the drugs with the most patents in Cyprus. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Cyprus? …
Which pharmaceutical drugs have the most drug patents in Cyprus? Read Post »
Annual Drug Patent Expirations for HETLIOZ+LQ Hetlioz Lq is a drug marketed by Vanda Pharms Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent for Vanda Pharms drug HETLIOZ LQ appeared first on DrugPatentW…
Annual Drug Patent Expirations for SYNJARDY+XR Synjardy Xr is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are seven…
The post New patent for Boehringer Ingelheim drug SYNJARDY XR appeared…
New patent for Boehringer Ingelheim drug SYNJARDY XR Read Post »
Annual Drug Patent Expirations for LYTGOBI Lytgobi is a drug marketed by Taiho Oncology and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent for Taiho Oncology drug LYTGOBI appeared first on DrugPate…
Annual Drug Patent Expirations for LUMRYZ Lumryz is a drug marketed by Avadel Cns and is included in one NDA. It is available from one supplier. There are fifteen patents…
The post New patent for Avadel Cns drug LUMRYZ appeared first on DrugPatentWatch…
Get new actionable insights and updates from BiotechBlog
